Skip to main content
Figure 1 | BMC Medical Genomics

Figure 1

From: Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes

Figure 1

Schematic representation of the study approach. Verification group1: Eighty-nine genes were selected for gene expression analysis using TaqMan Low Density Array, TLDA, see text for details. In the TLDA analysis, six favourable (F) and six unfavourable (UF) tumours were included. Verification group 2: Twelve candidate genes were selected for validation by TaqMan individual QPCR, TM (see Table 3 for selection criteria). A new, randomly selected set of favourable (n = 7) and unfavourable (n= 6) tumours were used in the analyses, and all samples were run in duplicates (×2).

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us